Case of the Month

February 2023

56-year old male patient with ipilimumab/ nivolumab-induced adrenalitis

Read more
Dezember 2022

69-year-old male patient with ipilimumab/nivolumab-induced Hepatitis, Thyroiditis, Hypophysitis, Vestibulopathy and Cochleitis

Read more
Dezember 2022

77-year-old patient with pembrolizumab-induced myocarditis

Read more
September 2022

77-year-old patient with ipilimumab/nivolumab-induced myositis of the lateral rectus muscle

Read more
August 2022

71-year-old patient with nivolumab-induced giant cell arteritis

Read more
Juli 2022

51-year-old patient with durvalumab-induced erythema multiforme

Read more
Juni 2022

56-year-old patient with bilateral vestibulopathy

Read more
February 2022

61-year-old patient with steroid-refractory irColitis and 2nd line therapy with infliximab, vedolizumab (α₄β₇ integrin blocker) and extracorporeal photopheresis (ECP)

Read more

Participate and document cases of rare, complex, severe and therapy-refractory side effects induced by immunotherapy

Join our team of experts for analysis of irAE

Initiate or contribute to research projects with regard to irAE

Access our Database